tiprankstipranks
Trending News
More News >

David R. McAvoy Insider Profile

4 Followers
David R. McAvoy, General Counsel at Endocyte, holds 13.03K shares in Teva Pharmaceutical (Ticker: TEVA), holds 16.37K shares in Fresh Tracks Therapeutics (Ticker: FRTX), holds 0.00 shares in Endocyte (Ticker: ECYT). Most recently, David R. McAvoy Bought ― shares of Teva Pharmaceutical on Sep 09, 2025 for an estimated value of $20.98K.
tipranks
David R. McAvoy

David R. McAvoy
Endocyte (ECYT)
General Counsel

Ranked #94,665 out of 103,431 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-60.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$256K
100.00%
A breakdown of David R. McAvoy's holdings

Insider Roles

Teva Pharmaceutical
(TEVA)
EVP, CLO
Roles that David R. McAvoy holds in companies

Most Profitable Insider Trade

Stock:
Fresh Tracks Therapeutics
(FRTX)
Rating:Informative Buy
Date:Sep 21, 2020 - Sep 21, 2021
Return:-11.60%
The most profitable trade made by David R. McAvoy

David R. McAvoy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ECYT
Endocyte
Dec 21, 2018
Uninformative Sell
50.86K
$0.00
FRTX
Fresh Tracks Therapeutics
Oct 04, 2023
Uninformative Buy
12.26K
$15.31K
Teva Pharmaceutical
Sep 09, 2025
EVP, CLO
Informative Buy
20.98K
$256.37K
List of latest transactions for each holding click on a transaction to see David R. McAvoy's performance on stock

David R. McAvoy insider profile FAQ

What is the percentage of profitable transactions made by David R. McAvoy?
The percentage of profitable transactions made by David R. McAvoy is 0%.
    What is the average return per transaction made by David R. McAvoy?
    The average return per transaction made by David R. McAvoy is -60.30%.
      What stocks does David R. McAvoy hold?
      David R. McAvoy holds: ECYT, FRTX, TEVA stocks.
        What was David R. McAvoy’s latest transaction?
        David R. McAvoy latest transaction was an Informative Buy of $20.98K.
          What was David R. McAvoy's most profitable transaction?
          David R. McAvoy’s most profitable transaction was an Informative Buy of FRTX stock on September 21, 2020. The return on the trade was -11.60%.
            What is David R. McAvoy's role in Endocyte?
            David R. McAvoy's role in Endocyte is General Counsel.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.